Alignment Healthcare, Inc. (ALHC) Tops Q2 EPS by 4c; offers guidance

Alignment Healthcare, Inc. (NASDAQ: ALHC) reported Q2 EPS of $0.17, $0.04 better than the analyst estimate of $0.13. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.31 billion.

GUIDANCE:

Alignment Healthcare, Inc. sees Q3 2026 revenue of $1.3-1.32 billion, versus the consensus of $1.315 billion.

Alignment Healthcare, Inc. sees FY2026 revenue of $5.195-5.225 billion, versus the consensus of $5.189 billion.

For earnings history and earnings-related data on Alignment Healthcare, Inc. (ALHC) click here.

You May Also Be Interested In

• JPMorgan Upgrades Diploma Plc. (DPLM:LN) to Overweight
• JPMorgan Starts Jersey Mike's Subs (JMKE) at Overweight
• Nomura/Instinet Reiterates Buy Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)